Literature DB >> 19892255

Steroid therapy of septic shock.

Charles L Sprung1, Serge Goodman, Yoram G Weiss.   

Abstract

Despite their potential benefits, corticosteroids have adverse affects and the benefits and risks must be balanced in determining whether they should be used or not. Some of the serious adverse affects noted in patients with critically illness have included superinfections and critical illness polyneuromyopathy. This article reviews the subject of steroid treatment of patients with septic shock and weighs the advantages and disadvantages of steroid treatment. It reviews and contrasts several low- and high-dose steroid studies, and makes recommendations for future practice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19892255     DOI: 10.1016/j.ccc.2009.07.002

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  12 in total

Review 1.  Phosphorylation mechanisms in intensive care medicine.

Authors:  Erica L Martin; V Marco Ranieri
Journal:  Intensive Care Med       Date:  2010-09-04       Impact factor: 17.440

2.  Validation of a gene expression-based subclassification strategy for pediatric septic shock.

Authors:  Hector R Wong; Natalie Z Cvijanovich; Geoffrey L Allen; Neal J Thomas; Robert J Freishtat; Nick Anas; Keith Meyer; Paul A Checchia; Richard Lin; Thomas P Shanley; Michael T Bigham; Derek S Wheeler; Lesley A Doughty; Ken Tegtmeyer; Sue E Poynter; Jennifer M Kaplan; Ranjit S Chima; Erika Stalets; Rajit K Basu; Brian M Varisco; Frederick E Barr
Journal:  Crit Care Med       Date:  2011-11       Impact factor: 7.598

3.  Efficacy of selective mineralocorticoid and glucocorticoid agonists in canine septic shock.

Authors:  Caitlin W Hicks; Daniel A Sweeney; Robert L Danner; Peter Q Eichacker; Anthony F Suffredini; Jing Feng; Junfeng Sun; Ellen N Behrend; Steven B Solomon; Charles Natanson
Journal:  Crit Care Med       Date:  2012-01       Impact factor: 7.598

4.  Hypothalamic-pituitary-adrenal axis in lethal canine Staphylococcus aureus pneumonia.

Authors:  Irene Cortés-Puch; Caitlin W Hicks; Junfeng Sun; Steven B Solomon; Peter Q Eichacker; Daniel A Sweeney; Lynnette K Nieman; Elizabeth M Whitley; Ellen N Behrend; Charles Natanson; Robert L Danner
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-10-07       Impact factor: 4.310

5.  The adrenal gland and corticosteroid therapy in sepsis: I certainly remain uncertain.

Authors:  Brian M Fuller
Journal:  Crit Care Med       Date:  2015-03       Impact factor: 7.598

6.  Low-dose steroids in adult septic shock: results of the Surviving Sepsis Campaign.

Authors:  Brian Casserly; Herwig Gerlach; Gary S Phillips; Stanley Lemeshow; John C Marshall; Tiffany M Osborn; Mitchell M Levy
Journal:  Intensive Care Med       Date:  2012-10-12       Impact factor: 17.440

Review 7.  The glucocorticoid receptor: a revisited target for toxins.

Authors:  Jeanette I Webster Marketon; Esther M Sternberg
Journal:  Toxins (Basel)       Date:  2010-06-09       Impact factor: 4.546

Review 8.  Therapeutic strategies for high-dose vasopressor-dependent shock.

Authors:  Estevão Bassi; Marcelo Park; Luciano Cesar Pontes Azevedo
Journal:  Crit Care Res Pract       Date:  2013-09-15

9.  Low-dose plasmid DNA treatment increases plasma vasopressin and regulates blood pressure in experimental endotoxemia.

Authors:  Thiago Malardo; Marcelo E Batalhão; Ademilson Panunto-Castelo; Luciana P Almeida; Everton Padilha; Isabela C Fontoura; Célio L Silva; Evelin C Carnio; Arlete A M Coelho-Castelo
Journal:  BMC Immunol       Date:  2012-11-08       Impact factor: 3.615

Review 10.  PI3K/Akt/mTOR, a pathway less recognized for staphylococcal superantigen-induced toxicity.

Authors:  Teresa Krakauer
Journal:  Toxins (Basel)       Date:  2012-11-15       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.